Effectiveness of selected broad spectrum antibiotics against Pseudomonas species isolated through the use of chloramphenicol
DOI:
https://doi.org/10.30574/gscbps.2018.5.3.0158Keywords:
Pseudomonas species, Chloramphenicol, Minimum inhibitory concentration, Broad spectrum antibiotics, Multi-drug resistanceAbstract
Greenish pigment producing Pseudomonas species were isolated from water samples using nutrient agar supplemented with 50 μg.ml-1 chloramphenicol. Broth cultures of three of the Pseudomonas isolates were prepared for minimum inhibitory concentration (MIC) determination by adjusting their turbidity using sterile normal saline to match the turbidity of McFarland standard No. 1 which is regarded to have a cell density of about 3 × 108 cfu/ml. The MIC of ciprofloxacin, erythromycin, and tetracycline against the three isolates was determined using the agar dilution method. The concentrations of the antibiotics used are 0.625, 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0, 160.0, 320.0, and 640.0 μg/ml. The results showed that the MIC of ciprofloxacin against the Pseudomonas isolates ranged from 5 – 640 μg/ml; the MIC of tetracycline against the isolates ranged from 5 – 640 μg/ml; and the MIC of erythromycin against the isolates ranged from 40 - 80 μg/ml. It is thus concluded that multidrug resistant species of Pseudomonas can be generated as a result of using chloramphenicol for the isolation of Pseudomonas, and that erythromycin can be effective in treating infections caused by Pseudomonas species that are resistant to ciprofloxacin and tetracycline.
Metrics
References
Abouseoud M, Yataghene A, Amrane A and Maachi R. (2010). Production of a biosurfactant by Pseudomonas fluorescens – Solubilizing and wetting capacity. Chemical Engineering Transactions, 20, 291-296.
Garbi C, Casasús L, Martinez-Álvarez R, Robla JI and Martín M. (2006). Biodegradation of oxadiazon by a soil isolated Pseudomonas fluorescens strain CG5: Implementation in an herbicide removal reactor and modelling. Water Research, 40(6), 1217–1223.
Otenio M H, da Silva MTL, Marques MLO, Roseiro JC and Bidoia ED. (2005). Benzene, Toluene and Xylene biodegradation by Pseudomonas putida CCMI 852. Brazilian Journal of Microbiology, 36(3), 258-261.
Peekate LP and Abu GO. (2017). Use of chloramphenicol in the differential enumeration of greenish pigment producing Pseudomonas. Basic Research Journal of Microbiology, 4(4), 33-41.
Butler T. (2011). Treatment of typhoid fever in the 21st century: promises and shortcomings. Clinical Microbiology and Infection, 17(7), 959-963.
Dasgupta A. (2012). Advances in antibiotic measurement. Advances in Clinical Chemistry, 56, 75-104.
Rose PW, Harnden A, Brueggemann AB, Perera R, Sheikh A, Crook D and Mant D. (2005). Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. The Lancet, 366(9479), 37-43.
Supiyaphun P, Kerekhanjanarong V, Koranasophonepun J and Sastarasadhit V. (2000). Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. Journal of the Medical Association of Thailand, 83(1), 61-68.
Prescott LM, Harley JP and Klein DA. (1999). Microbiology, fourth edition. The McGraw-Hill companies Inc., New York, 471, 475, 685-689.
Ory EM and Yow EM. (1963). The use and abuse of the broad spectrum antibiotics. Journal of the American Medical Association, 185(4), 273-284.
Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA and Ward A. (1988). Ciprofloxacin: A review of its antibacterial activity, pharmacokinetics properties and therapeutic use. Drugs, 35(4), 373-447.
Balouiri M, Sadik M and Ibnsouda SK. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis, 6, 71-79.
Jorgensen JH and Ferraro MJ. (2009). Antimicrobial susceptibility testing: A review of general principle and contemporary practices. Clinical Infectious Diseases, 49, 1749-1755.
Clinical and Laboratory Standards Institute. (2012). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA
Manilla PN, Ogali RE and Uzoukwu BA. (2001). Undergraduate chemistry: Fundamental principles. Timi Hyacinth Enterprises, Lagos, Nigeria, 55-56.
Lysenko O. (1961). Pseudomonas – An attempt at a general classification. Journal of General Microbiology, 25, 379-408.
Reynolds MT, Falkiner FR, Hardy R and Keane CT. (1979). Differentiation of fluorescent Pseudomonas by their effect on milk agar. Journal of Medical Microbiology, 12, 379-382.
Hamud-Socoro AA. (2004). Pseudomonas aeruginosa resistance to tetracycline and triclosan. Cantaurus, 12, 7-9.
Li X-Z, Livermore DM and Nikaido H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrobial Agents and Chemotherapy, 38(8), 1732-1741.
Naghmouchi K, Le LC, Baah J and Drider D. (2012). Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Research in Microbiology, 163(2), 101-108.
Su H-C, Ramkissoon K, Doolittle J, Clark M, Khatun J, Secrest A, Giddings MC. (2010). The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins. Antimicrobial Agents and Chemotherapy, 54(11), 4626-4635.
Lomholt JA and Kilian M. (2003). Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis. British Journal of Ophthalmology, 87(10), 1238-1240.
Morita Y, Tomida J and Kawamura Y. (2013). Responses of Pseudomonas aeruginosa to antimicrobials. Frontiers in Microbiology, 4, 1-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
